AptarGroup Q4 net income +62% to $101M; adj. EPS $1.52; pharma sales +8% FY

APTARGROUP, INC.

2024-FY EPS reported $5.53 revenue$3,582,890,000

Q4 reported EPS $1.49 (+60% YoY); adjusted EPS $1.52 (+27% YoY).
Full-year net income $375M (+32%); adjusted EPS $5.64 (+18%).
Pharma core sales +4% Q4; Closures core +7% Q4; Beauty core -3% Q4.
Q1 2025 adj. EPS guidance $1.11-$1.19; currency headwind ~$0.07; tax rate 25-27%.
Board authorized $500M share repurchase; quarterly dividend $0.45/share declared.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.